About us | About Scoope | Contact us

 Sponsor Links
| Articles | White Papers | Presentations 

Articles                                                                                                  TOP

Simon Fraser University takes steps to support open access publishing

(straight.com): In the past few months, Simon Fraser University has taken steps to support open-access publishing of scholarly articles. SFU's senate library committee endorsed in January an open-access strategy for the university library. In February, SFU created an open-access fund to support researchers at the university who publish articles in open-access journals. While reading many academic journals often requires a paid subscription, open-access journals are freely available on the Internet. But authors typically have to pay article processing charges to publish in open-access journals.
Click here

The CONSORT 2010 statement - a "service history" for clinical trials

(openaccesscentral.com): The CONSORT 2010 statement was co-published by eight journals. Like the original statement published in 1996, the revised guidelines are intended to improve the reporting of randomized controlled trials by providing a checklist of essential items for use by authors, reviewers and editors. The latest revision draws on new evidence and experience gained since the last update in 2001.
Click here

Student-Run Journals Encourage Scholarship, Creative Endeavors

(uanews.org): The Arizona Journal of Environmental Law&Policy is among the most recent UA-student run publications to be launched. The Web-based, student run journal will enable students, faculty and others to publish on environmental issues from legal, scientific, economic and public policy perspectives, among others.
Click here

Global Healthcare Experts Set Forth Guidelines for Improving 'Risk-Sharing' Schemes for Expensive New Treatments

(pharmalive.com): Wolters Kluwer Pharma Solutions, Inc. has published the collective recommendations of an international team of healthcare experts on how payers can improve their risk-sharing approaches for expensive new therapies and technology. Participants of the 2009 Banff Summit on evidence development, held in Calgary, Canada, reached a consensus about how to better evaluate and design payer reimbursement mechanisms for high-cost medical treatments. Participants included leading risk-sharing experts from Australia, Canada, the U.K. and the U.S., all who were signatories on a consensus statement. The resulting guidelines were published for the first time in the Adis journal PharmacoEconomics.
Click here

Medical Journals: Still Too Lazy to ID Pharma-Funded Research

(bnet.com): An editorial in the Journal of the American Medical Association describes a "disturbing example of inappropriate conduct" in studies for the GlaxoSmithKline's diabetes drug Avandia. JAMA's editorial calls for independent researchers to oversee all studies funded by drug companies to ensure that the data can be checked by someone not on the company payroll. JAMA already requires authors to disclose all payments when they publish in its pages.
Click here

For banner ads click here